Galectin-3 levels are elevated following nintedanib treatment.
Shochet GE, Pomerantz A, Shitrit D, Bardenstein-Wald B, Ask K, Surber M, Rabinowicz N, Levy Y, Benchetrit S, Edelstein E, Zitman-Gal T.
Shochet GE, et al. Among authors: pomerantz a.
Ther Adv Chronic Dis. 2020 Nov 27;11:2040622320968412. doi: 10.1177/2040622320968412. eCollection 2020.
Ther Adv Chronic Dis. 2020.
PMID: 33708368
Free PMC article.